Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Pt 1
|
pubmed:dateCreated |
1991-4-30
|
pubmed:abstractText |
To elucidate the pathophysiological significance of endogenous atrial natriuretic polypeptide (ANP) in hypertension, we investigated the biosynthesis and secretion of ANP in deoxycorticosterone acetate (DOCA)-salt hypertensive rats and also examined the effect of passive immunization with monoclonal antibody raised against alpha-rat ANP on the development of hypertension in DOCA-salt rats. The plasma ANP level in DOCA-salt rats was significantly elevated in comparison to control rats. While the atrial ANP concentration in DOCA-salt rats was not significantly altered, the atrial level of ANPmRNA in DOCA-salt rats was two-fold higher than that in control rats. These results suggest the augmented biosynthesis of ANP in the atrium and the oversecretion of ANP from the heart in DOCA-salt rats. The levels of ANP and ANPmRNA in the ventricle of DOCA-salt rats exhibited significant increases, compared with those in control rats, suggesting the induction of ANP gene expression in the ventricle of DOCA-salt hypertensive rats under pre/after overload. Weekly intravenous administrations of monoclonal antibody with high affinity for alpha-rat ANP significantly augmented the rise in blood pressure of DOCA-salt rats. These results support the hypothesis that the augmented secretion of ANP is one of the defensive mechanisms to counteract high arterial pressure in this model of hypertension.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Atrial Natriuretic Factor,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Probes,
http://linkedlifedata.com/resource/pubmed/chemical/Desoxycorticosterone,
http://linkedlifedata.com/resource/pubmed/chemical/RNA
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0895-7061
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
39-44
|
pubmed:dateRevised |
2009-2-24
|
pubmed:meshHeading |
pubmed-meshheading:1706603-Animals,
pubmed-meshheading:1706603-Antibodies, Monoclonal,
pubmed-meshheading:1706603-Atrial Natriuretic Factor,
pubmed-meshheading:1706603-Blood Pressure,
pubmed-meshheading:1706603-Blotting, Northern,
pubmed-meshheading:1706603-DNA Probes,
pubmed-meshheading:1706603-Desoxycorticosterone,
pubmed-meshheading:1706603-Gene Expression,
pubmed-meshheading:1706603-Heart Atria,
pubmed-meshheading:1706603-Heart Ventricles,
pubmed-meshheading:1706603-Hypertension,
pubmed-meshheading:1706603-Male,
pubmed-meshheading:1706603-Nucleic Acid Hybridization,
pubmed-meshheading:1706603-RNA,
pubmed-meshheading:1706603-Radioimmunoassay,
pubmed-meshheading:1706603-Rats,
pubmed-meshheading:1706603-Rats, Inbred Strains
|
pubmed:year |
1991
|
pubmed:articleTitle |
Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody.
|
pubmed:affiliation |
Department of Medicine, Kyoto University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|